Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN26100007
IGF::OT::IGF EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541712 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | HHSN261201200034I |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $846.3K |
| Current contract value | $846.3K |
| Potential contract value / ceiling | $846.3K |
| Start date | Jun 15, 2015 |
| Current end date | May 31, 2021 |
| Potential end date | May 31, 2021 |
| Latest award activity | Aug 30, 2021 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 30, 2021 | P00006 | $2.6K | CLINICAL PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH TASK ORDER TITLE: EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION TASK OR |
| Aug 25, 2021 | P00005 | $-7.7K | CLINICAL PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH TASK ORDER TITLE: EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION TASK OR |
| May 19, 2020 | P00004 | $0 | CLINICAL PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH TASK ORDER TITLE: EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION TASK |
| Jun 14, 2019 | P00003 | $0 | IGF::OT::IGF BASE CONTRACT TITLE: CLINICAL PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH TASK ORDER TITLE: EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION TASK ORDER PERIOD OF PERFORMANCE: 06/15/2015-05/31/2020 |
| May 16, 2018 | 2 | $-1.2K | IGF::OT::IGF BASE CONTRACT TITLE: CLINICAL PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCHTASK ORDER TITLE: EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATIONTASK ORDER PERIOD OF PERFORMANCE: 06/15/2015-06/14/2019 |
| Sep 15, 2016 | 1 | $-29.7K | IGF::OT::IGF BASE CONTRACT TITLE: CLINICAL PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCHTASK ORDER TITLE: EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATIONTASK ORDER PERIOD OF PERFORMANCE: 06/15/2015-06/14/2019 |
| Jun 15, 2015 | 0 | $882.4K | IGF::OT::IGF EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.